Current Neuro-Oncology
Volume
26 Number 20
20 September 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 20, 20 September
Lim-Fat MJ, Wen PY, Touat M, Puduvalli VK, Iorgulescu JB.
MGMT
promoter methylation and survival following chemotherapy for WHO
grade 4 IDH-mutant astrocytoma.
Neuro
Oncol. 2024 Sep 11:noae157. doi:
10.1093/neuonc/noae157. PMID:
39277807. Observational study˰
ˍ
Mareček D, Kopecká V, Matěj R, Strýček
O.
Bilateral thalamic glioblastoma
presenting as parkinsonism: A case report.
Parkinsonism
Relat Disord. 2024 Sep 11;128:107147. doi:
10.1016/j.parkreldis.2024.107147. PMID:
39276721. Case report˰
ˍ
Hu G, Tian B, Han S, Wang S, Hacker M, Li X, Bai X.
Prognostic
evaluation in recurrent glioma through 11C-Choline
PET/CT imaging.
EJNMMI
Res. 2024 Sep 12;14(1):84. doi:
10.1186/s13550-024-01146-x. PMID:
39266803. Observational study. ˍ
Rixe O, Villano JL, Wesolowski R, Noonan AM, Puduvalli VK,
Wise-Draper TM, Curry R, Yilmaz E, Cruze C, Ogretmen B, Tapolsky
G, Takigiku R.
A first-in-human phase
1 study of BXQ-350, a first-in-class sphingolipid metabolism
regulator, in patients with advanced/recurrent solid tumors or
high-grade gliomas.
Clin
Cancer Res. 2024 Sep 12. doi:
10.1158/1078-0432.CCR-24-1721. PMID:
39264252. Interventional study˰
ˍ
Sun Z, Feng D, Zhu R.
A case of adult
medulloblastoma.
Asian J Surg. 2024 Sep
13:S1015-9584(24)01979-1. doi:
10.1016/j.asjsur.2024.08.239. PMID:
39271311. Case report. ˍ
Reimann RR, Gramatzki D, Bink A, Hench J, Frank S, Haberecker M,
Hortobagyi T, Egervari K, Merkler D, Aldape K, Weller M.
Long
survival in a patient with fumarate hydratase mutation-associated
glioma.
J
Neuropathol Exp Neurol. 2024 Sep 16:nlae100. doi:
10.1093/jnen/nlae100. PMID:
39279228. Case report. ˍ
Hickman RA, Miller AM, Holle BM, Jee J, Liu SY, Ross D, Yu H,
Riely GJ, Ombres C, Gewirtz AN, Reiner AS, Nandakumar S, Price A,
Kaley TJ, Graham MS, Vanderbilt C, Rana S, Hill K, Chabot K,
Campos C, Nafa K, Shukla N, Karajannis M, Li B, Berger M, Ladanyi
M, Pentsova E, Boire A, Brannon AR, Bale T, Mellinghoff IK, Arcila
ME.
Real-world experience with
circulating tumor DNA in cerebrospinal fluid from patients with
central nervous system tumors.
Acta
Neuropathol Commun. 2024 Sep 17;12(1):151. doi:
10.1186/s40478-024-01846-4. PMID:
39289779. Observational study. ˍ
Sekino Y, Sonoda Y, Shibahara I, Mizusawa J, Sasaki K, Sekita T,
Ichikawa M, Igaki H, Kinoshita M, Kumabe T, Shibahara J, Ichimura
K, Arakawa Y, Fukuda H; Brain Tumor Study Group (BTSG) of the
Japan Clinical Oncology Group (JCOG); Narita Y.
Protocol
digest of a phase III randomized trial of gross total resection
versus possible resection of fluid-attenuated inversion
recovery-hyperintense lesion on MRI for newly diagnosed
supratentorial glioblastoma: JCOG2209 (FLAMINGO).
Jpn
J Clin Oncol. 2024 Sep 17:hyae130. doi:
10.1093/jjco/hyae130. PMID:
39292165. Interventional study protocol˰
ˍ
Laetsch TW, Ludwig K, Williams PM, Roy-Chowdhuri S, Patton DR,
Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Mhlanga
J, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV,
Janeway KA, Seibel NL, Parsons DW.
Phase
II Study of Samotolisib in Children and Young Adults With Tumors
Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin
Pathway Alterations: Pediatric MATCH APEC1621D.
JCO
Precis Oncol. 2024 Sep 19;8:e2400258. doi:
10.1200/PO.24.00258. PMID:
39298693. Interventional study˰
ˍ
*An S, Lin H, Zhang Y, Pang B, Yan H, Liu Y, Wang L, Wu Y, Chai R,
Jia W, Wang Y.
Central nervous system
dissemination in spinal cord astrocytomas: association with H3
K27M mutation.
J
Neurosurg Spine. 2024 Sep 20:1-10. doi:
10.3171/2024.6.SPINE24233. PMID:
39303298. Observational study. ˍ
Shigekawa S, Inoue A, Endo T, Muto J, Inoue T, Kanematsu R,
Mitsuhara T, Umebayashi D, Mizuno M, Hida K, Kunieda T;
Investigators of Intramedullary Spinal Cord Tumors in the
Neurospinal Society of Japan.
Optimal
treatment strategy for low-grade spinal cord astrocytoma: a
retrospective, multicenter analysis by the Neurospinal Society of
Japan.
J
Neurosurg Spine. 2024 Sep 20:1-9. doi:
10.3171/2024.5.SPINE24457. PMID:
39303310. Observational study˰
ˍ
Bruhn H, Tavelin B, Rosenlund L, Henriksson R.
Do
presenting symptoms predict treatment
decisions and survival in glioblastoma? Real-world data from 1458
patients in the Swedish brain tumor
registry.
Neurooncol
Pract. 2024 Apr 23;11(5):652-659. doi:
10.1093/nop/npae036. PMID:
39279780. Observational study. ˍ
*Guo E, Gupta M, Rossong H, Boone L, Manoranjan B, Ahmed S,
Stukalin I, Lama S, Sutherland GR.
Healthcare
spending versus mortality in central nervous system
cancer: Has anything changed?
Neurooncol
Pract. 2024 Apr 27;11(5):566-574. doi:
10.1093/nop/npae039. PMID:
39279779. Observational study˰
ˍ
Zelt S, Cooney T, Yu S, Daral S,
Krebs B, Markan R, Manley P, Kieran M, Govinda Raju S.
Disease
burden and healthcare utilization in pediatric low-grade glioma: A
United States retrospective study of linked claims and electronic
health records.
Neurooncol
Pract. 2024 Apr
27;11(5):583-592. doi:
10.1093/nop/npae037. PMID:
39279771. Observational study. ˍ
Bazer DA, Kolchinski A, Bush NAO, Clarke JL, Bagley SJ, Schreck
KC.
No drug holidays in BRAFV600E
glioma patients: An argument for dose reduction of targeted
therapies.
Neurooncol
Pract. 2024 May 24;11(5):660-664. doi:
10.1093/nop/npae046. PMID:
39279775. Case report˰
ˍ
Byskov CS, Muhic A, Dahlrot RH, Haslund CA, Guldberg TL, Høyer
M, Nyström PW, Dysager L, Hansen S, Haldbo-Classen L, Trip
AK, Lassen-Ramshad Y, Weber B, Lukacova S, Hansen CR, Kallehauge
JF.
Selection for proton radiotherapy
of grade 1-3 glioma patients.
Clin
Transl Radiat Oncol. 2024 Aug 13;48:100836. doi:
10.1016/j.ctro.2024.100836. PMID:
39258242. Observational study. ˍ
Munagama CL, Rajendiran V, Silva S.
A
Case Report on a Common Tumour With an Uncommon Presentation:
Glioblastoma.
Cureus.
2024 Aug 14;16(8):e66830. doi:
10.7759/cureus.66830. PMID:
39280398. Case report. ˍ
Romero-Luna G, Mendez-Granda AL, Adame-Paredes R, Galvan-Salazar
G, De Juambelz-Cisneros PP, Fernandez-Alvarado B, Pazos-Gómez
F.
Occurrence of Glioblastoma Five
Years After Resection of Atypical Meningioma at the Same Anatomic
Site: A Case Report.
Cureus.
2024 Aug 14;16(8):e66871. doi:
10.7759/cureus.66871. PMID:
39280441. Case report. ˍ
Dev ID, Sahay A, Puranik AD, Purandare NC, Agrawal A, Shah S,
Choudhury S, Ghosh S, Rangarajan V.
Rare
Cases of Extracranial Metastases from High-grade Glioma Detected
on FET PET-CT with Histopathological Confirmation.
Indian
J Nucl Med. 2024 Aug 17;39(3):216-219. doi:
10.4103/ijnm.ijnm_34_24. PMID:
39291064. Case report. ˍ
Avuthu OPR, Salunkhe S, Patil MG, C Buch A, Mane SV, Chugh A.
Pilomyxoid Astrocytoma Presenting With
Developmental Regression: A Case Report.
Cureus.
2024 Aug 19;16(8):e67167. doi:
10.7759/cureus.67167. PMID:
39295729. Case report. ˍ
Borges de Almeida G, Pascuzzo R, Mambrin F, Aquino D, Verri M,
Moscatelli M, Del Bene M, DiMeco F, Silvani A, Pollo B, Grisoli M,
Doniselli FM.
The Role of Amide Proton
Transfer (APT)-Weighted Imaging in Glioma: Assessment of Tumor
Grading, Molecular Profile and Survival in Different Tumor
Components.
Cancers
(Basel). 2024 Aug 29;16(17):3014. doi:
10.3390/cancers16173014. PMID:
39272871. Observational study. ˍ
McConville C, Lastakchi S, Al Amri A, Ngoga D, Fayeye O,
Cruickshank G.
Local Delivery of
Irinotecan to Recurrent GBM Patients at Reoperation Offers a Safe
Route of Administration.
Cancers
(Basel). 2024 Aug 29;16(17):3008. doi:
10.3390/cancers16173008. PMID:
39272866. Observational study. ˍ
Agiananda F, Aninditha T, Sofyan HR, Savitri I, Karnasih A,
Puspaseruni PA, Putri CK.
AB068.
Psychiatric disorder in central nervous system tumor patients and
its related factors.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB068. doi:
10.21037/cco-24-ab068. PMID:
39295386. Observational study. ˍ
Chen Z, Guo C, Yang Q, Lin F, Hu W, Xi S, Zhang J, Jiang X, Li D,
Chen Y, Ke C, Zhou J, Zhou Z, Ceng S.
AB048.
Evidence of effectiveness of neoadjuvant camrelizumab and apatinib
in patients with recurrent high-grade gliomas.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB048. doi:
10.21037/cco-24-ab048. PMID:
39295366. Interventional study. ˍ
Humam N, Widodo D.
AB058. Giant
bilateral intraventricle ependymoma in pediatric patient with
essential tremor as a main symptom: a rare case report.
Chin
Clin Oncol. 2024 Aug;13(Suppl 1):AB058. doi:
10.21037/cco-24-ab058. PMID:
39295376. Case report. ˍ
*Li D, Xu P, Yang Q, Guo C, Xi S, Sai K, Chen Z.
AB047.
Searching for factors relating to long-term survivors of
glioblastoma.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB047. doi:
10.21037/cco-24-ab047. PMID:
39295365. Observational study. ˍ
Sonoda Y, Sekino Y, Mizusawa J, Shibahara I, Sasaki K, Sekita T,
Ichikawa M, Igaki H, Kinoshita M, Shibahara J, Ichimura K, Arakawa
Y, Fukuda H, Narita Y.
AB012. A phase
III randomized trial of gross total resection versus possible
resection of fluid-attenuated inversion recovery (FLAIR)
hyperintensity lesion on magnetic resonance image for newly
diagnosed supratentorial glioblastoma (JCOG2209).
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB012. doi:
10.21037/cco-24-ab012. PMID:
39295330. Interventional study. ˍ
Takada S, Takeuchi Y, Makino Y, Yamamoto E, Sano N, Tanji M,
Mineharu Y, Arakawa Y.
AB014. The
accurate classification of high-grade glioma, IDH-wildtype, is
based on methylation profiling: a case report.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB014. doi:
10.21037/cco-24-ab014. PMID:
39295332. Case report. ˍ
Tanaka T, Tamura R, Takei J, Yamamoto Y, Akasaki Y, Murayama Y,
Miyake K, Sasaki H.
AB052. A
multicenter prospective exploratory phase II study of neoadjuvant
bevacizumab for newly diagnosed malignant glioma.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB052. doi:
10.21037/cco-24-ab052. PMID:
39295370. Interventional study. ˍ
Umemura Y, Clarke N, Al-Holou W, Elaimy A, Scott A, Leung D, Kim
M, Ferris S, Thomas J, Heth J, Schipper M, Suresh K, Lawrence T,
Wahl D.
AB036. Targeting glioblastoma
de-novo purine metabolism to overcome chemoradiation resistance:
an interim result of phase 0/1 clinical trial in newly diagnosed
and recurrent glioblastoma.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB036. doi:
10.21037/cco-24-ab036. PMID:
39295354. Interventional study. ˍ
Zhong W, Mao J, Wu D, Peng J, Ye W.
The
efficacy of stereotactic radiotherapy followed by bevacizumab and
temozolomide in the treatment of recurrent glioblastoma: a case
report.
Front
Pharmacol. 2024 Sep 4;15:1401000. doi:
10.3389/fphar.2024.1401000. PMID:
39295944. Case report. ˍ
**Alyasova AV, Ben Ammar AM, Zarkua VT, Rerberg AG.
A
case report of successful combined intra-arterial immunotherapy
and cytokine genetic therapy treatment in a patient with recurrent
glioblastoma.
Chin
Clin Oncol. 2024 Sep 6:cco-24-34. doi:
10.21037/cco-24-34. PMID:
39260431. Case report. ˍ
Gerritsen JKW, Young JS, Krieg SM, Jungk C, Ille S, Schucht P,
Nahed BV, Broekman MLD, Berger M, De Vleeschouwer S, Vincent AJPE.
Resection versus biopsy in patients
with glioblastoma (RESBIOP study): study protocol for an
international multicentre prospective cohort study (ENCRAM 2202).
BMJ
Open. 2024 Sep 10;14(9):e081689. doi:
10.1136/bmjopen-2023-081689. PMID:
39260848. Interventional study protocol. ˍ
Isikay AI, Gurses ME, Gecici NN, Baylarov B, Cekic E, Narin F,
Karakaya D, Hanalioglu S, Bilginer B.
Congenital
Brain Tumors: Surgical Outcomes and Long-Term Prognostic Factors.
World
Neurosurg. 2024 Sep 10:S1878-8750(24)01559-6. doi:
10.1016/j.wneu.2024.09.021. PMID:
39265942. Observational study˰
ˍ
Stegat L, Eckhardt A, Gocke A, Neyazi S, Pohl L, Schmid S,
Dottermusch M, Frank S, Pinnschmidt H, Herms J, Glatzel M, Snuderl
M, Schweizer L, Thomas C, Neumann J, Dorostkar MM, Schüller
U, Wefers AK.
Integrated analyses
reveal two molecularly and clinically distinct subtypes of H3
K27M-mutant diffuse midline gliomas with prognostic significance.
Acta
Neuropathol. 2024 Sep 10;148(1):40. doi:
10.1007/s00401-024-02800-3. PMID:
39256213. Laboratory investigation. ˍ
Wang YC, Wu KL, Jung SM, Wu CT.
Metastasis
of World Health Organization Grade II and Grade III Meningiomas:
Long-Term Survival and Associated Factor Analysis.
World
Neurosurg. 2024 Sep 10:S1878-8750(24)01555-9. doi:
10.1016/j.wneu.2024.09.013. PMID:
39265944. Observational study˰
ˍ